Stay updated with breaking news from Mark Joinnides. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
CAPE CANAVERAL, Fla., April 19, 2024 (GLOBE NEWSWIRE) -- Vaxxinity, Inc. (“Vaxxinity”, “we”, “us” or the “Company”) (Nasdaq: VAXX), a U.S. company pioneering the development of a new class of
CAPE CANAVERAL, Fla., April 19, 2024 -- Vaxxinity, Inc. , a U.S. company pioneering the development of a new class of medicines, today announced its intention to voluntarily delist from the Nasdaq...
Presentation will address the Company’s clinical data in Parkinson’s diseaseCAPE CANAVERAL, Fla., March 28, 2024 -- Vaxxinity, Inc. , a U.S. company pioneering the development of a new class of...
Presentation will address the Company’s clinical data in Parkinson’s disease...
CAPE CANAVERAL, Fla., March 27, 2024 (GLOBE NEWSWIRE) -- Vaxxinity, Inc. (Nasdaq: VAXX), a U.S. company pioneering the development of a new class of...